Delivery of long-acting injectable antivirals: best approaches and recent advances

PURPOSE OF REVIEWTreatment of chronic disease in a manner that promotes compliance and patient adherence has necessitated the consideration for drug delivery approaches that reduce the burden of regimens requiring daily treatment. Long-acting injectable (LAI) products have been developed in many dis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current opinion in infectious diseases 2015-12, Vol.28 (6), p.603-610
Hauptverfasser:	Hickey, Magali B, Merisko-Liversidge, Elaine, Remenar, Julius F, Namchuk, Mark
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-HIV Agents - administration & dosage Anti-HIV Agents - pharmacokinetics Antiviral Agents - administration & dosage Antiviral Agents - pharmacokinetics Delayed-Action Preparations - administration & dosage Delayed-Action Preparations - pharmacokinetics Drug Delivery Systems HIV Infections - drug therapy HIV Infections - immunology HIV Infections - prevention & control Humans Immunotherapy, Adoptive Injections Medication Adherence - statistics & numerical data Tuberculosis - drug therapy Tuberculosis - immunology Tuberculosis - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!